advanced ovarian cancer

The potential role of neoadjuvant chemotherapy in advanced ovarian cancer
M. Baekelandt

International Journal of Gynecologic Cancer Oct 2003, 13 (Suppl 2) 163-168; DOI: 10.1136/ijgc-00009577-200311001-00006
A retrospective analysis of neoadjuvant platinum-based chemotherapy versus up-front surgery in advanced ovarian cancer
H. Steed, A. M. Oza, J. Murphy, S. Laframboise, G. Lockwood, D. De Petrillo, J. Sturgeon, B. Rosen

International Journal of Gynecologic Cancer Jan 2006, 16 (Suppl 1) 47-53; DOI: 10.1136/ijgc-00009577-200602001-00008
A phase II clinical trial of topotecan and carboplatin in patients with newly diagnosed advanced epithelial ovarian cancer
F. Vecchione, R. Fruscio, T. Dell'Anna, A. Garbi, R. Garcia Parra, S. Corso, A. A. Lissoni

International Journal of Gynecologic Cancer Feb 2007, 17 (2) 367-372; DOI: 10.1111/j.1525-1438.2007.00797.x
Long-term survival and prognostic factors in advanced epithelial ovarian cancer with special emphasis upon the effects of protocol inclusion
K. Bertelsen, J. E. Andersen

International Journal of Gynecologic Cancer Apr 1994, 4 (3) 180-187; DOI: 10.1046/j.1525-1438.1994.04030180.x
The prognostic value of serum CA 125 in patients with advanced ovarian carcinoma: an analysis of 573 patients by the Medical Research Council Working Party on Gynaecological Cancer
P. M. Fayers, G. Rustin, R. Wood, A. Nelstrop, R. C.F. Leonard, P. Wilkinson, D. Cruickshank, E. J. Mcallister, C. W.E. Redman, D. Parker, I. V. Scott, M. L. Slevin, J. E. Roulston

International Journal of Gynecologic Cancer Aug 1993, 3 (5) 285-292; DOI: 10.1046/j.1525-1438.1993.03050285.x
Laparoscopic Debulking Surgery in the Management of Advanced Ovarian Cancer After Neoadjuvant Chemotherapy
Giacomo Corrado, Emanuela Mancini, Giuseppe Cutillo, Ermelinda Baiocco, Patrizia Vici, Domenico Sergi, Lodovico Patrizi, Maria Saltari, Alberto Baffa, Enrico Vizza

International Journal of Gynecologic Cancer Sep 2015, 25 (7) 1253-1257; DOI: 10.1097/IGC.0000000000000491
Economic Analysis of Neoadjuvant Chemotherapy Versus Primary Debulking Surgery for Advanced Epithelial Ovarian Cancer Using an Aggressive Surgical Paradigm
Ashley L. Cole, Emma L. Barber, Anagha Gogate, Arthur-Quan Tran, Stephanie B. Wheeler

International Journal of Gynecologic Cancer Jun 2018, 28 (6) 1077-1084; DOI: 10.1097/IGC.0000000000001271
Current Clinical Practice in Cytoreductive Surgery for Advanced Ovarian Cancer: A European Survey
David Cibula, Rene Verheijen, Alberto Lopes, Ladislav Dusek, on behalf of the ESGO Council

International Journal of Gynecologic Cancer Oct 2011, 21 (7) 1219-1224; DOI: 10.1097/IGC.0b013e318227c971
The Role of Diaphragmatic Surgery During Interval Debulking After Neoadjuvant Chemotherapy: an Analysis of 74 Patients With Advanced Epithelial Ovarian Cancer
Dimitris Tsolakidis, Frederic Amant, Toon Van Gorp, Karin Leunen, Patrick Neven, Ignace Vergote

International Journal of Gynecologic Cancer May 2010, 20 (4) 542-551; DOI: 10.1111/IGC.0b013e3181d4de23
Prognostic factors in ovarian carcinoma stage III patients. Can biomarkers improve the prediction of short- and long-term survivors?
J. KAERN, M. AGHMESHEH, J. M. NESLAND, H. E. DANIELSEN, B. SANDSTAD, M. FRIEDLANDER, C. TROPÉ

International Journal of Gynecologic Cancer Nov 2005, 15 (6) 1014-1022; DOI: 10.1136/ijgc-00009577-200511000-00003

Main menu

advanced ovarian cancer

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

advanced ovarian cancer

Pages